Bright S. Ashimatey, et al. Twelve-month Natural History Study of CEP290-associated Retinal Degeneration. Presented at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting. April 23 – 27, 2023.

May

2

Editas Medicine Announces First Quarter 2024 Results Conference Call and Upcoming Investor Events

May

1

Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration

Apr

22

Editas Medicine to Present Pre-clinical Data Demonstrating Progression of in vivo Medicines Pipeline at the American Society of Gene and Cell Therapy Annual Meeting